131 results on '"Harris, Stewart"'
Search Results
2. Time in uncontrolled hyperglycemia before insulin initiation in people living with type 2 diabetes: A systematic literature review
3. Impact of the COVID-19 Pandemic on Adults With Type 2 Diabetes Care and Clinical Parameters in a Primary Care Setting in Ontario, Canada: A Cross-sectional Study
4. Impact of the COVID-19 Pandemic on Antihyperglycemic Prescriptions for Adults With Type 2 Diabetes in Canada: A Cross-sectional Study
5. The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
6. Predicting Real-world Non-severe Hypoglycemia Risk in Diabetes (iNPHORM, USA)
7. Predicting Real-world Severe Hypoglycemia Risk in Diabetes (iNPHORM, USA)
8. Insulin-sparing Effects of Oral Semaglutide: An Analysis of PIONEER 8
9. Family Physician Clinical Inertia in Managing Hypoglycemia
10. Real-World Incidence and Risk Factors for Daytime and Nocturnal Non-Severe Hypoglycemia in Adults With Type 2 Diabetes Mellitus on Insulin and/or Secretagogues (InHypo-DM Study, Canada)
11. Patient perspectives and experiences of basal insulin (BI) titration in type 2 diabetes (T2D): A US cross-sectional survey
12. COVID-19 Impact on Diabetes Management (iNPHORM, USA)
13. Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?
14. Changes in adiposity mediate the associations of diet quality with insulin sensitivity and beta-cell function
15. Primary and Secondary Cardiovascular Prevention Among First Nations Peoples With Type 2 Diabetes in Canada: Findings From the FORGE AHEAD Program
16. 24 - Implementation and Evaluation of a Diabetes Registry in First Nations Communities in Canada: Data From the FORGE AHEAD Study
17. 69 - Age- and Sex-Specific Incidence of Severe Hypoglycemia in Type 2 Diabetes (InHypo-DM Study)
18. Beyond the Sick Role: The Many Roles of Adults With Type 1 and Type 2 Diabetes in the Management of Hypoglycemia—The InHypo-DM Study, Canada
19. Closing the indigenous health gap in Canada: Results from the TransFORmation of IndiGEnous PrimAry HEAlthcare delivery (FORGE AHEAD) program
20. Explaining the variability in cardiovascular risk factors among First Nations communities in Canada: a population-based study
21. 119 - Real-World Incidence and Risk Indicator of Nonsevere Hypoglycemia in T1DM (InHypo-DM Study)
22. 120 - Closing the Indigenous Health Gap in Canada: Results From the TransFORmation of IndiGEnous PrimAry HEAlthcare Delivery (FORGE AHEAD) Program
23. 116 - Impaired Awareness of Hypoglycemia Increases Severe Hypoglycemia Rates in T2DM (InHypo-DM Study)
24. Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement
25. Raising the Bar on Low Blood Sugar Management: Who is at Risk of Non-Severe Hypoglycemia? (InHypo-DM Study)
26. The “Unspoken” Truth: Suboptimal Reporting of Severe Hypoglycemia in Diabetes (InHypo-DM Study)
27. Uncovering the Key Real-World Risk Indicator of Severe Hypoglycemia in Type 2 Diabetes Mellitus (InHypo-DM Study)
28. Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes
29. TITRATION: A Randomized Study to Assess 2 Treatment Algorithms with New Insulin Glargine 300 units/mL
30. Type 2 Diabetes (T2D) Management in Primary Care: Still Room for Improvement
31. IDegLira is Efficacious Across Baseline HbA1C Categories in Subjects with Type 2 Diabetes Uncontrolled on SU, GLP-1RA or Insulin Glargine: Analyses from Completed Phase 3b Trials
32. Impact of BMI on HbA1C Reduction in Response to IDegLira in Subjects with Type 2 Diabetes (T2D) Uncontrolled on SU, GLP-1RA or Insulin Glargine: Analyses from Completed Phase 3b Trials
33. Hypoglycemia Rates in Type 2 Diabetes Mellitus Differ by Medication Type (InHypo-DM Canada)
34. The Impact of Baseline BMI and HbA1c on Glycemic Control After Treatment with Fast-Acting Insulin Aspart in Individuals with Type 2 Diabetes
35. Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) Titrated Once Weekly (1W) versus Twice Weekly (2W) in Patients with T2D Uncontrolled on Oral Antidiabetic Drugs: DUAL VI Study
36. Experiences of Hypoglycemia Management from the Significant Others' Perspective: Insight from the InHypo-DM Study (Canada)
37. The Diabetes Evaluation Framework for Innovative National Evaluations (DEFINE): Construct and Content Validation Using a Modified Delphi Method
38. Impact de l’IMC sur la réduction de l’HbA 1c sous IDegLira chez des diabétiques de type 2 insuffisamment contrôlés sous sulfamides, agonistes des récepteurs au GLP-1 ou insuline Glargine U100 : analyses d’études de phase IIIb
39. Efficacité et sécurité d’un algorithme pragmatique de titration à 1 unité par jour par le patient (INSIGHT) pour l’insuline Glargine 300 U/ml (Gla-300)
40. Étude DUAL VI : efficacité et tolérance de l’insuline Degludec/liraglutide (IDegLira) en titration hebdomadaire versus bimensuelle chez des diabétiques de type 2 insuffisamment contrôlés sous Antidiabétiques oraux (ADO)
41. Call to action: A new path for improving diabetes care for Indigenous peoples, a global review
42. A Population-Based Study on Incidence and Associated Risk Factors for Hypoglycemia in Canada: The InHYPO-DM Study
43. A National Survey of Physicians' and Allied Health Professionals' Practices and Perspectives Regarding Hypoglycemia Management: The InHYPO-DM StudyImage 8
44. The LONGevity & Type 1 Diabetes Macrovascular Epidemiology (LONGTIME) Study: Carotid Intima Media Thickness, LV Strain and Endothelial Dysfunction in Type 1 Diabetes of 50 Years Duration
45. Safety and Efficacy of a Pragmatic Self-Titration 1 Unit/Day (INSIGHT) Algorithm for Insulin Glargine 300 U/mL (Gla-300)
46. Assessing Clinical Readiness for Chronic Disease Management in Canada's First Nations: Baseline Data from the FORGE AHEAD Clinical Readiness Consultation Tool
47. Dietary Patterns and Type 2 Diabetes Mellitus in a First Nations Community
48. Best Practices for the Prevention and Management of Diabetes and Obesity-Related Chronic Disease among Indigenous Peoples in Canada: A Review
49. Applying Atherosclerotic Risk Prevention Guidelines to Elderly Patients: A Bridge Too Far?
50. Use of Diabetes Registry Data for Comparing Indices of Diabetes Management: A Comparison of 2 Urban Sites in Canada and Colombia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.